INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800
INO-4800 was going to be developed as a COVID-19 heterologous booster vaccine, but INOVIO, a biotechnology company specialising in the development and commercialization of DNA medicines to help treat and prevent infectious diseases, cancer, and diseases linked to HPV, has…